AGT and COVID-19: The accumulated experimental data, the structural features that relate to DIZE, ARBs and AngII, together with the positive clinical effects from the use of ARBs in the treatment of COVID-19, provide the fundamental basis that DIZE and ARBs may be target compounds for COVID-19 therapy.